BSX (Boston Scientific Corporation) Stock Financials & Earnings | Market Cap Arena

BSXBoston Scientific Corporation

Mkt Cap$105B

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Revenue (TTM)$20.1B

Net Income (TTM)$2.9B

EPS (TTM)$1.93

Free Cash Flow (TTM)$3.6B

Gross Margin69.0%

Op. Margin19.8%

Net Margin14.4%

FCF Margin18.1%

P/S Ratio (TTM)5.2x

P/E Ratio (TTM)36.2x

YoY Rev Growth+19.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$3.4B	$2.1B	$515M
Q2 23	$3.6B	$2.3B	$551M
Q3 23	$3.5B	$2.2B	$558M
Q4 23	$3.7B	$2.3B	$558M
Q1 24	$3.9B	$2.4B	$644M
Q2 24	$4.1B	$2.6B	$747M
Q3 24	$4.2B	$2.6B	$674M
Q4 24	$4.6B	$2.7B	$589M
Q1 25	$4.7B	$3.0B	$896M
Q2 25	$5.1B	$3.4B	$819M
Q3 25	$5.1B	$3.5B	$1.1B
Q4 25	$5.3B	$3.9B	$1.2B

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	8.0x	115.9x
Q2 23	7.8x	114.6x
Q3 23	7.6x	85.1x
Q4 23	7.3x	65.7x
Q1 24	7.1x	59.0x
Q2 24	6.9x	57.2x
Q3 24	6.6x	58.4x
Q4 24	6.2x	56.4x
Q1 25	6.0x	51.4x
Q2 25	5.7x	41.8x
Q3 25	5.4x	37.5x
Q4 25	5.2x	36.2x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$190M	$69M
Q2 23	$658M	$452M
Q3 23	$698M	$492M
Q4 23	$957M	$690M
Q1 24	$164M	-$81M
Q2 24	$813M	$658M
Q3 24	$1.0B	$698M
Q4 24	$1.5B	$1.2B
Q1 25	$541M	$354M
Q2 25	$1.3B	$1.1B
Q3 25	$1.3B	$1.2B
Q4 25	$1.4B	$1.0B

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$121M
Q2 23	$206M
Q3 23	$206M
Q4 23	$267M
Q1 24	$245M
Q2 24	$155M
Q3 24	$304M
Q4 24	$293M
Q1 25	$187M
Q2 25	$190M
Q3 25	$181M
Q4 25	$351M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+12.0%	+11.9%
Q2 23	+10.9%	+10.2%
Q3 23	+11.3%	+9.6%
Q4 23	+14.9%	+13.4%
Q1 24	+13.8%	+11.8%
Q2 24	+14.5%	+10.7%
Q3 24	+19.3%	+19.1%
Q4 24	+22.4%	+25.4%
Q1 25	+20.9%	+17.3%
Q2 25	+22.8%	+25.8%
Q3 25	+20.3%	+13.6%
Q4 25	+15.9%	+2.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$55M	1.6%
Q2 23	$60M	1.7%
Q3 23	$59M	1.7%
Q4 23	$59M	1.6%
Q1 24	$63M	1.6%
Q2 24	$195M	4.7%
Q3 24	-$61M	-1.4%
Q4 24	$69M	1.5%
Q1 25	$74M	1.6%
Q2 25	$75M	1.5%
Q3 25	$79M	1.6%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$337M	$1.2B
Q2 23	$359M	$1.4B
Q3 23	$356M	$1.2B
Q4 23	$363M	$1.4B
Q1 24	$366M	$1.4B
Q2 24	$383M	$1.4B
Q3 24	$407M	$1.6B
Q4 24	$460M	$1.6B
Q1 25	$443M	$1.6B
Q2 25	$526M	$1.7B
Q3 25	$514M	$1.7B
Q4 25	$569M	$1.8B

Revenue Segments

Quarter	Cardiovascular	Med Surg
Q1 23	$2.1B	$1.3B
Q2 23	$2.2B	$1.4B
Q3 23	$2.2B	$1.3B
Q4 23	$2.3B	$1.4B
Q1 24	$2.4B	$1.4B
Q2 24	$2.6B	$1.5B
Q3 24	$2.7B	$1.5B
Q4 24	$2.9B	$1.6B
Q1 25	$3.1B	$1.6B
Q2 25	$3.3B	$1.7B
Q3 25	$3.3B	$1.7B
Q4 25	$3.5B	$1.8B

Revenue by Geography

Quarter	Non-US	United States
Q1 23	$1.4B	$2.0B
Q2 23	$1.5B	$2.1B
Q3 23	$1.4B	$2.1B
Q4 23	$1.5B	$2.2B
Q1 24	$1.6B	$2.3B
Q2 24	$1.7B	$2.5B
Q3 24	$1.6B	$2.6B
Q4 24	$1.7B	$2.9B
Q1 25	$1.7B	$3.0B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$570M	$0	$570M
Q2 23	$426M	$0	$426M
Q3 23	$952M	$0	$952M
Q4 23	$865M	$0	$865M
Q1 24	$2.3B	$0	$2.3B
Q2 24	$2.9B	$0	$2.9B
Q3 24	$2.5B	$0	$2.5B
Q4 24	$414M	$0	$414M
Q1 25	$725M	$0	$725M
Q2 25	$534M	$0	$534M
Q3 25	$1.3B	$0	$1.3B
Q4 25	$2.0B	$0	$2.0B

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	1.45B	+0.2%
Q2 23	1.46B	+0.7%
Q3 23	1.48B	+1.3%
Q4 23	1.48B	+0.1%
Q1 24	1.48B	+0.3%
Q2 24	1.48B	+0.2%
Q3 24	1.49B	+0.2%
Q4 24	1.49B	+0.2%
Q1 25	1.49B	+0.2%
Q2 25	1.49B	+0.0%
Q3 25	1.50B	+0.1%
Q4 25	1.50B	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$308K	24K
FY 15	$299K	25K
FY 16	$311K	27K
FY 17	$312K	29K
FY 18	$307K	32K
FY 19	$298K	36K
FY 20	$261K	38K
FY 21	$290K	41K
FY 22	$282K	45K
FY 23	$297K	48K
FY 24	$316K	53K
FY 25	$340K	59K

BSX (Boston Scientific Corporation) Stock Financials & Earnings | Market Cap Arena